Press Release Verastem Oncology Doses First Patient in TARGET-D 202 Phase 2 Registration-Directed Trial of VS-7375 for KRAS G12D-Mutated Advanced Non-Small Cell Lung Cancer Jul 22
Press Release The Trade Desk Announces Date of Second Quarter 2026 Financial Results and Conference Call Jul 22
Press Release Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call Jul 22
Press Release iVeena Delivery Systems Announces Positive End-of-Phase 1 FDA Meeting for IVMED-85 Jul 22
Press Release FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer Jul 22